Phase 3 Study of ANP Therapy vs. TMZ for Optic Pathway Glioma
Clinical trial NCT01260103 · WITHDRAWN
Trial details
- NCT number
- NCT01260103
- Sponsor
- Burzynski Research Institute
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2016-12-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.